Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVARIAN: Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion
NCT06677554Phase 3Recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- May 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sulfur hexafluoride in adnexal torsion (2 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Evaluation of the two-stage diagnostic strategy effectiveness at 38 months. Started May 2025; status: recruiting.
02
Drugs
sulfur hexafluoride
03
Conditions
adnexal torsion
Beyond the preview
Go deeper on NCT06677554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06677554.